<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><rec-number>5027</rec-number><ref-type>Journal Article</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jansen, Lynn A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Local IRBs, Multicenter Trials, and the Ethics of Internal Amendments</style></title><secondary-title><style face="normal" font="default" size="100%">IRB: Ethics &amp; Human Research</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Clinical</style></keyword><keyword><style  face="normal" font="default" size="100%">MEDICINE</style></keyword><keyword><style  face="normal" font="default" size="100%">Placebos</style></keyword><keyword><style  face="normal" font="default" size="100%">PSYCHOSES</style></keyword><keyword><style  face="normal" font="default" size="100%">schizophrenia</style></keyword><keyword><style  face="normal" font="default" size="100%">THERAPEUTICS</style></keyword></keywords><taxonomies><taxonomy><style  face="normal" font="default" size="100%">Institutional Review Boards</style></taxonomy><taxonomy><style  face="normal" font="default" size="100%">Human Research Subjects</style></taxonomy><taxonomy><style  face="normal" font="default" size="100%">Psychology</style></taxonomy><taxonomy><style  face="normal" font="default" size="100%">Medicine</style></taxonomy></taxonomies><pubtype><style  face="normal" font="default" size="100%">Journal Article</style></pubtype><audience-level><style  face="normal" font="default" size="100%">ug</style></audience-level><dates><year><style  face="normal" font="default" size="100%">2005</style></year></dates><volume><style face="normal" font="default" size="100%">27</style></volume><pages><style face="normal" font="default" size="100%">7-11</style></pages><isbn><style face="normal" font="default" size="100%">01937758</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Discusses a case study presented before a local institutional review board to review a protocol for a randomized, double-blind, placebo-controlled trial for the treatment of schizophrenia. Criteria for the eligibility of individuals to participate in the study; Evaluation of responses to standard available treatments for schizophrenia; Justification of the use of placebos.</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Article</style></work-type><accession-num><style face="normal" font="default" size="100%">17649201</style></accession-num><notes><style face="normal" font="default" size="100%">Jansen, Lynn A. 1; Affiliation: 1: Senior Medical Ethicist, John J. Conley Department of Ethics, St. Vincent's, Manhattan, and Assistant Professor of Medicine, New York Medical College, New York, NY; Source Info: Jul/Aug2005, Vol. 27 Issue 4, p7; Subject Term: SCHIZOPHRENIA; Subject Term: PSYCHOSES; Subject Term: PLACEBOS (Medicine); Subject Term: MEDICINE &amp; psychology; Subject Term: THERAPEUTICS; Subject Term: CLINICAL trials; Number of Pages: 5p; Document Type: Article</style></notes></record></records></xml>